WallStreetZenWallStreetZen

NASDAQ: BDSX
Biodesix Inc Stock

$1.58+0.11 (+7.48%)
Updated Feb 23, 2024
BDSX Price
$1.58
Fair Value Price
N/A
Market Cap
$142.95M
52 Week Low
$1.03
52 Week High
$2.27
P/E
-1.8x
P/B
-98.86x
P/S
2.99x
PEG
N/A
Dividend Yield
N/A
Revenue
$44.03M
Earnings
-$63.35M
Gross Margin
70.6%
Operating Margin
-121.72%
Profit Margin
-143.9%
Debt to Equity
-61.02
Operating Cash Flow
-$23M
Beta
1.13
Next Earnings
Mar 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BDSX Overview

Biodesix, Inc. operates as a data-driven diagnostic solutions provider. Biodesix offers blood-based tests to assess the risk of lung cancer, identify the appropriate treatment pathway, and help physicians to reclassify the risk of malignancy in patients with suspicious lung nodules. Biodesix was incorporated in 2005 and is headquartered in Boulder, CO.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BDSX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BDSX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BDSX is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
BDSX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more BDSX due diligence checks available for Premium users.

Be the first to know about important BDSX news, forecast changes, insider trades & much more!

BDSX News

Valuation

BDSX fair value

Fair Value of BDSX stock based on Discounted Cash Flow (DCF)
Price
$1.58
Fair Value
$2.34
Undervalued by
32.33%
BDSX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BDSX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.8x
Industry
39.41x
Market
33.56x

BDSX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-98.86x
Industry
4.29x

BDSX's financial health

Profit margin

Revenue
$13.5M
Net Income
-$10.9M
Profit Margin
-81.2%
BDSX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BDSX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$86.8M
Liabilities
$88.2M
Debt to equity
-61.02
BDSX's short-term liabilities ($32.65M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BDSX's long-term liabilities ($55.58M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BDSX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BDSX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.8M
Investing
-$5.9M
Financing
$12.2M
BDSX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BDSX vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
BDSX$142.95M+7.48%-1.80x-98.86x
NOTV$143.91M-6.22%-4.29x0.57x
FONR$153.14M+1.92%12.07x0.93x
GTH$120.53M0.00%-1.04x1.52x
STIM$95.19M+0.30%-2.79x2.51x

Biodesix Stock FAQ

What is Biodesix's quote symbol?

(NASDAQ: BDSX) Biodesix trades on the NASDAQ under the ticker symbol BDSX. Biodesix stock quotes can also be displayed as NASDAQ: BDSX.

If you're new to stock investing, here's how to buy Biodesix stock.

What is the 52 week high and low for Biodesix (NASDAQ: BDSX)?

(NASDAQ: BDSX) Biodesix's 52-week high was $2.27, and its 52-week low was $1.03. It is currently -30.4% from its 52-week high and 53.4% from its 52-week low.

How much is Biodesix stock worth today?

(NASDAQ: BDSX) Biodesix currently has 90,476,295 outstanding shares. With Biodesix stock trading at $1.58 per share, the total value of Biodesix stock (market capitalization) is $142.95M.

Biodesix stock was originally listed at a price of $13.57 in Nov 2, 2020. If you had invested in Biodesix stock at $13.57, your return over the last 3 years would have been -88.36%, for an annualized return of -51.17% (not including any dividends or dividend reinvestments).

How much is Biodesix's stock price per share?

(NASDAQ: BDSX) Biodesix stock price per share is $1.58 today (as of Feb 23, 2024).

What is Biodesix's Market Cap?

(NASDAQ: BDSX) Biodesix's market cap is $142.95M, as of Feb 26, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biodesix's market cap is calculated by multiplying BDSX's current stock price of $1.58 by BDSX's total outstanding shares of 90,476,295.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.